Literature DB >> 19682267

Mucosal mast cells mediate motor response induced by chronic oral exposure to ovalbumin in the rat gastrointestinal tract.

E Traver1, R Torres, F de Mora, P Vergara.   

Abstract

We previously demonstrated that oral chronic exposure to ovalbumin (OVA) causes intestinal hypermotility in Sprague-Dawley rats. In this study, the objective was to determine the mechanism of action of OVA and the role of mucosal mast cells in the regulation of motor activity in this model. Rats were orally exposed to OVA during 6 weeks. Intestinal mucosal mast cells (IMMCs) were counted and rat mast cell protease II (RMCPII) measured in duodenum, jejunum, ileum and colon. Anti-OVA IgE, IgG, and IL-4 were measured in serum. Eosinophils and IgE(+) cells were counted in jejunum. In an additional study rats were treated with the mast cell stabilizer ketotifen and mast cell number, RMCPII concentration and motor activity in vitro were evaluated. OVA exposed rats showed an increase in mucosal mast cell number and in RMCPII content in small intestine and colon. However, variables of a Th(2) type response were not affected by exposure to OVA: (i) neither OVA specific IgE nor IgG were found; (ii) IL-4 did not increase and, (iii) the number of eosinophils and IgE(+) cells was identical in the exposed and unexposed groups. These results brought us to hypothesize a possible non-Ig-mediated action of OVA on mast cells. Ketotifen significantly diminished the response to OVA: Ketotifen reduced the number of mast cells and the RMCPII content and blocked increased intestinal contractility. In addition ketotifen modified motor response in both OVA exposed and unexposed animals giving evidence of the importance of mast cells in intestine motor activity driving.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682267     DOI: 10.1111/j.1365-2982.2009.01377.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  8 in total

1.  Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents.

Authors:  Lindsey L Kennedy; Laura A Hargrove; Allyson B Graf; Taylor C Francis; Kyle M Hodges; Quy P Nguyen; Yoshi Ueno; John F Greene; Fanyin Meng; Victoria D Huynh; Heather L Francis
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

2.  Mast cells in gastrointestinal disease.

Authors:  David B Ramsay; Sindu Stephen; Marie Borum; Lysandra Voltaggio; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-12

Review 3.  Mast cells.

Authors:  Terez Shea-Donohue; Jennifer Stiltz; Aiping Zhao; Luigi Notari
Journal:  Curr Gastroenterol Rep       Date:  2010-10

Review 4.  Mast cells: an expanding pathophysiological role from allergy to other disorders.

Authors:  Preet Anand; Baldev Singh; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-06       Impact factor: 3.000

5.  Development and characterization of an effective food allergy model in Brown Norway rats.

Authors:  Mar Abril-Gil; Alba Garcia-Just; Francisco J Pérez-Cano; Àngels Franch; Margarida Castell
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

6.  Lipopolysaccharides facilitate colonic motor alterations associated to the sensitization to a luminal antigen in rats.

Authors:  Ferran Jardi; Monica Aguilera; Patri Vergara; Vicente Martinez
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

7.  Esophageal Mast Cell Infiltration in a 32-Year-Old Woman with Noncardiac Chest Pain.

Authors:  Keol Lee; Hee Jin Kwon; In Young Kim; Kwai Han Yoo; Seulkee Lee; Yang Won Min; Poong-Lyul Rhee
Journal:  Gut Liver       Date:  2016-01       Impact factor: 4.519

Review 8.  The Role of Mast Cells in Irritable Bowel Syndrome.

Authors:  Kang Nyeong Lee; Oh Young Lee
Journal:  Gastroenterol Res Pract       Date:  2016-12-28       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.